8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes

被引：253

作者：

Eckhardt, Matthias ^{[1
]}

Langkop, Elke ^{[1
]}

Mark, Michael ^{[2
]}

Tadayyon, Mob ^{[2
]}

Thomas, Leo ^{[2
]}

Nar, Herbert ^{[3
]}

Pfrengle, Waldemar ^{[4
]}

Guth, Brian ^{[5
]}

Lotz, Ralf ^{[5
]}

Sieger, Peter ^{[5
]}

Fuchs, Holger ^{[6
]}

Himmelsbach, Frank ^{[1
]}

机构：

[1] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Chem Res, D-88400 Biberach, Germany

[2] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Metab Dis Res, D-88400 Biberach, Germany

[3] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Lead Discovery, D-88400 Biberach, Germany

[4] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Chem Dev, D-88400 Biberach, Germany

[5] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Drug Discovery Support, D-88400 Biberach, Germany

[6] Boehringer Ingelheim Pharm GmbH & Co KG, Dept Drug Metab & Pharmacokinect, D-88400 Biberach, Germany

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2007年 / 50卷 / 26期

关键词：

D O I：

10.1021/jm701280z

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A new chemical class of potent DPP-4 inhibitors structurally derived from the xanthine scaffold for the treatment of type 2 diabetes has been discovered and evaluated. Systematic structural variations have led to 1 (BI 1356), a highly potent, selective, long-acting, and orally active DPP-4 inhibitor that shows considerable blood glucose lowering in different animal species. 1 is currently undergoing clinical phase IIb trials and holds the potential for once-daily treatment of type 2 diabetics.

引用

页码：6450 / 6453

页数：4

共 23 条

[1] Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes [J].

Augeri, DJ ;

Robl, JA ;

Betebenner, DA ;

Magnin, DR ;

Khanna, A ;

Robertson, JG ;

Wang, AY ;

Simpkins, LM ;

Taunk, P ;

Huang, Q ;

Han, SP ;

Abboa-Offei, B ;

Cap, M ;

Xin, L ;

Tao, L ;

Tozzo, E ;

Welzel, GE ;

Egan, DM ;

Marcinkeviciene, J ;

Chang, SY ;

Biller, SA ;

Kirby, MS ;

Parker, RA ;

Hamann, LG .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) :5025-5037

[2] The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases [J].

Augustyns, K ;

Van der Veken, P ;

Senten, K ;

Haemers, A .

CURRENT MEDICINAL CHEMISTRY, 2005, 12 (08) :971-998

[3] DPP-4 inhibitors and their potential role in the management of type 2 diabetes [J].

Barnett, A. .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (11) :1454-1470

[4] Glucagon-like peptide-1 and the islet β-cell:: Augmentation of cell proliferation and inhibition of apoptosis [J].

Drucker, DJ .

ENDOCRINOLOGY, 2003, 144 (12) :5145-5148

[5] Rigidity and flexibility of dipeptidyl peptidase IV: Crystal structures of and docking experiments with DPIV [J].

Engel, M ;

Hoffmann, T ;

Manhart, S ;

Heiser, U ;

Chambre, S ;

Huber, R ;

Demuth, HU ;

Bode, W .

JOURNAL OF MOLECULAR BIOLOGY, 2006, 355 (04) :768-783

[6] Discovery of alogliptin: A potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV [J].

Feng, Jun ;

Zhang, Zhiyuan ;

Wallace, Michael B. ;

Stafford, Jeffrey A. ;

Kaldor, Stephen W. ;

Kassel, Daniel B. ;

Navre, Marc ;

Shi, Lihong ;

Skene, Robert J. ;

Asakawa, Tomoko ;

Takeuchi, Koji ;

Xu, Rongda ;

Webb, David R. ;

Gwaltney, Stephen L., II .

JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (10) :2297-2300

[7]

Himmelsbach F., 2004, [No title captured], Patent No. [WO2004/018468, 2004018468]

[8] Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug [J].

Idris, Iskandar ;

Donnelly, Richard .

DIABETES OBESITY & METABOLISM, 2007, 9 (02) :153-165

[9]

KANSTRUP AB, 2002, Patent No. 2002002560

[10] DEGRADATION OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE AND TRUNCATED GLUCAGON-LIKE PEPTIDE-1 IN-VITRO AND IN-VIVO BY DIPEPTIDYL PEPTIDASE-IV [J].

KIEFFER, TJ ;

MCINTOSH, CHS ;

PEDERSON, RA .

ENDOCRINOLOGY, 1995, 136 (08) :3585-3596

← 1 2 3 →